The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide FLUTICASONE PROP HFA 220 MCG 12GM pharmaceutical products. The $2,074.52 order has a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, to deliver a comprehensive range of pharmaceuticals and medical supplies to military treatment facilities worldwide. This single-award IDC serves as the primary contract vehicle for Amerisourcebergen to support the Department of Defense. The delivery order was not set aside for any socioeconomic program.
Generated 5/19/24, 9:05 AM